NLM Logo

sparsentan MeSH Supplementary Concept Data 2024


MeSH Supplementary
sparsentan
Unique ID
C000634424
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000634424
Entry Term(s)
(1,1'-biphenyl)-2-sulfonamide, 4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-
4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2'-(ethoxymethyl)-2-biphenylsulfonamide
4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2'-(ethoxymethyl)biphenyl-2-sulfonamide
RE-021
Heading Mapped to
*Spiro Compounds
*Sulfonamides
Frequency
1
Note
a dual endothelin type A (ETA) and angiotensin II type 1 receptor antagonist
Source
J Am Soc Nephrol. 2018 Nov;29(11):2745-2754.
Date of Entry
2019/09/23
Revision Date
2019/09/23
sparsentan Preferred
RE-021 Narrower
4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2'-(ethoxymethyl)-2-biphenylsulfonamide Broader
page delivered in 0.004s